Latest News- Human Vaccine Market: Intramuscular is expected to lead the Route Of Administration segment during 2024-2028

The Human Vaccine Market is being driven by Increase in pediatric population

The Human Vaccine Market is expected to grow at a CAGR of 9.49% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 29.1 billion. The global vaccine market is experiencing significant growth due to the increasing prevalence of infectious diseases and life-threatening conditions such as cancer and HIV. While advancements in vaccine availability have led to a decrease in new disease cases in certain regions, the need for effective vaccines to combat these diseases persists. Consequently, vendors are investing heavily in research and development to produce vaccines for various diseases, driving market expansion during the forecast period. This trend is particularly notable in the areas of infectious diseases, where new vaccines are constantly being developed to address emerging health threats. Additionally, the development of vaccines for life-threatening conditions, such as cancer and HIV, represents a significant growth opportunity for vendors in this market. 

Get more information on Human Vaccine Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Route Of Administration
  • Intramuscular
  • Subcutaneous
  • Oral
• End-user
  • Pediatrics
  • Adults
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
  • Asia
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Increase in pediatric population
• Need for novel vaccines for chronic infections
• Public immunization programs funded by governments

However, the market also witnesses some limitations, which are as follows:

• Concerns about the safety of vaccines
• Challenges associated with R and D and manufacturing
• Need for annual reformulations of vaccines to match circulating strains

Benefits of Buying Global Human Vaccine Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Human Vaccine Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The human vaccine market encompasses various types of vaccines, including those for COVID-19, measles, mumps, rubella, diphtheria, tetanus, pertussis, rotavirus, human papillomavirus, and others. These vaccines protect against infectious diseases such as Dengue fever, Influenza, Tuberculosis, Malaria, Chikungunya, HIV, and Hepatitis B. Vaccination may cause side effects like soreness, swelling, redness, fever, rash, achiness, and allergic reactions. Toxoid vaccines use inactivated toxins, while mRNA vaccines use a piece of the virus's genetic material. Vaccine hesitancy and immunization awareness are crucial in ensuring the effectiveness of these preventive measures. Other diseases addressed by vaccines include measles, mumps, rubella, diphtheria, tetanus, pertussis, rotavirus, human papillomavirus, and cervical cancer. Drugs may also be used in conjunction with vaccines to enhance their efficacy.

Market Research Overview

The human vaccine market, a significant segment of the global pharmaceuticals industry, encompasses the development, production, and distribution of vaccines for various infectious diseases, including COVID-19, Dengue fever, Influenza, Tuberculosis, Malaria, and Chikungunya. According to Technavio, the global pharmaceuticals market, which includes entities involved in R&D and manufacturing of generic and non-generic drugs, veterinary drugs, and human vaccines, is projected to expand due to several key drivers. Among these, the increasing global population aging, with a predicted rise in the number of individuals over 60 years old, significantly influences the market's growth trajectory.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/